DocGo Q4 revenue $120.8M, net loss $7.6M; FY 2025 EBITDA margin guidance cut to ~5%

DocGo Inc.

2024-FY EPS reported $0.18 revenue$616,555,132

Q4 2024 revenue $120.8M, down from $199.2M Q4 2023 on migrant wind-down; net loss $7.6M vs net income $8.0M.
Full-year 2024 revenue $616.6M (down 1.2% YoY), net income $13.4M, adjusted EBITDA $60.3M (up from $54.0M).
2025 revenue guidance unchanged at $410-450M; adjusted EBITDA margin guidance cut to ~5% from previous 8-10%.
Migrant program wind-down reduced Q4 revenue by ~$9M and EBITDA by $5.3M; increased loss reserves cut EBITDA by $3.2M.
Surpassed 700,000 patient lives assigned for care gap closure programs; Q4 NPS of 86 for these programs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.